Clinical Trials Logo

Cardiac Dysfunction clinical trials

View clinical trials related to Cardiac Dysfunction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03866564 Completed - Chronic Pain Clinical Trials

Football Players Health Study In Person Assessments Study

IPA
Start date: April 22, 2019
Phase:
Study type: Observational

The aim of the Football Players Health Study (FPHS) is to advance the understanding of the complex and inter-related pathways that can develop into player related illness and disability. Former National Football League players will be given the opportunity to undergo 2&1/2 days of rigorous assessment in the areas of Cardiac Dysfunction, Neurocognitive Disease, Chronic Pain, and Sleep Apnea to attempt to define the pathology among former professional athletes.

NCT ID: NCT02581280 Completed - Cardiac Dysfunction Clinical Trials

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Start date: December 2014
Phase:
Study type: Observational

Extracorporeal membrane oxygenation (ECMO) is the device which increases the supply of oxygen to the body tissues in vitro and to assist in heart and lung function. Venoarterial (VA) ECMO is used in patients with cardiogenic shock, cardiac arrest, ventricular arrhythmia and is able to secure a time to self-recovery by reducing the excessive stimulation applied to the heart. However, in ECMO patients, pharmacokinetics of drugs are changing such as increased volume of distribution (Vd) or decreased clearance (CL). For this reason, it is hard to provide the best treatment in ECMO patients. The study is to evaluate whether the PK of drugs is influenced by VA ECMO and to recommend the optimal dosing strategies for proposed drugs in adult patients receiving VA ECMO.

NCT ID: NCT02320539 Completed - Clinical trials for Subarachnoid Hemorrhage

MicroRNA Diagnostics in Subarachnoid Hemorrhage 2

Start date: November 2014
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to validate results from a related trial (NCT01791257) and to compare the profile of microRNA in blood from patients suffering subarachnoid hemorrhage with and without systemic complications.